Form 4: BlackRock Health Sciences Trust Portfolio Manager Reports Transactions in BME
SEC Form 4 Filing
Christopher Accettella, a Portfolio Manager at BlackRock Health Sciences Trust, reports transactions involving common stock and phantom shares of BME on January 31, 2025.
Summary
- On January 31, 2025, Christopher Accettella, a Portfolio Manager at BlackRock Health Sciences Trust (BME), engaged in transactions involving the company's common stock and phantom shares.
- Accettella acquired 202.0159 shares of common stock.
- Accettella disposed of 202.0159 shares of common stock at a price of $40.92.
- Accettella acquired 174.1202 phantom shares.
- Accettella disposed of 59.5415, 58.7753, and 83.6991 phantom shares.
- Following these transactions, Accettella directly owns 820.65 shares of common stock and varying amounts of phantom shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock and phantom share transactions.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for insiders of publicly traded companies, providing transparency into their trading activities. It reflects the actions of a portfolio manager within BlackRock Health Sciences Trust, a closed-end fund focused on the health sciences sector.
Comparison to Industry Standards
- Form 4 filings are standard practice for company insiders and are comparable across all publicly traded companies.
- The transactions reported are specific to Christopher Accettella's portfolio management role at BlackRock Health Sciences Trust and do not directly relate to industry-wide benchmarks.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by providing insight into the portfolio manager's actions.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely negligible.
Key Dates
| Date | Description |
|---|---|
| January 31, 2022 | Reporting Person was granted phantom shares payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| January 31, 2023 | Reporting Person was granted phantom shares payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| January 31, 2024 | Reporting Person was granted phantom shares payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| January 31, 2025 | Date of transactions involving common stock and phantom shares. |
| February 04, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.